Epithalon has been discussed in published scientific literature involving peptide biology, telomere biology, cellular aging research models, gene expression analysis, molecular signaling pathways, and controlled laboratory investigations
This helps to get the most out of it
Thats where IV infusion therapy steps in
This paper demonstrates that c-Myb transcriptionally regulates CDO1 and inhibition of CDO1 expression upregulates GPX4 (Hao et al., 2017)
These effects were achieved through the regulation of the Akt/mTOR/GSK-3 signaling pathway, positioning ESP as a promising therapeutic agent for addressing cognitive decline associated with AD (Luo et al., 2022)
Pharm Nanatechnol 10(1):2441